RxDoctor Payments Data

Kara Dixon, PA

Medical · Hopkinsville, KYNPI 1851673412

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.8% of the total across 258 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Johnson & Johnson at 31.0% of the total.

$5,104in general payments, 2019–2025

Across 258 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • AbbVie$1K
  • Novartis$462
  • Sanofi$283
  • Amgen$250
  • Regeneron Healthcare Solutions, Inc.$240
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$4,63391%
  • Education$4709%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,104 in reported general payments places this provider in the 85th percentile of 222 medical providers in Kentucky.

See all medical providers in Kentucky

Medicare billing

Part B allowed, 2024
$30,530
Medicare patients
286
Services billed
966

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa22$449,097
Dupixent PenDupilumab26$93,926
Dupixent SyringeDupilumab12$47,008
Clobetasol Propionate108$3,857
Fluorouracil34$2,490
Ketoconazole156$2,461
Betamethasone Dipropionate26$931
Doxycycline Hyclate59$821
Tretinoin13$761
Triamcinolone Acetonide60$717
Hydrocortisone87$602
Clindamycin Phosphate28$571
Ammonium Lactate31$557
Fluconazole28$339
Mometasone Furoate25$283

Paid to pharmacies, not to this prescriber.

Other medical in Hopkinsville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →